Veterinary Medicines

Program suspensie voor oraal gebruik bij katten

Authorised
  • Lufenuron
  • Lufenuron
Download as PDF

Product identification

Medicine name:
Program suspensie voor oraal gebruik bij katten
Active substance:
  • Lufenuron
  • Lufenuron
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lufenuron
    266.00
    milligram(s)
    /
    3.80
    gram(s)
  • Lufenuron
    133.00
    milligram(s)
    /
    1.90
    gram(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53BC01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8270
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."